Evaluation of Effectiveness of Risperdal® Consta® Compared to Abilify® Over a Two-Year Period in Patients With Schizophrenia

This study has been completed.

Study NCT00299702 Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

First Received: March 3, 2006 Last Updated: July 8, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	January 2009
Primary Completion Date:	January 2009 (Final data collection date for primary outcome measure)